دورية أكاديمية
أعرض في EDS

Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y 14 Receptor Antagonists.

التفاصيل البيبلوغرافية
العنوان: Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y 14 Receptor Antagonists.
المؤلفون: Wen Z; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Pramanik A; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Lewicki SA; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Jung YH; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Gao ZG; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Randle JCR; Random Walk Ventures, LLC, 108 Lincoln Street Unit 6B, Boston, Massachusetts 02111, United States., Cronin C; Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, Connecticut 06030, United States., Chen Z; Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, Missouri 63104, United States., Giancotti LA; Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, Missouri 63104, United States., Whitehead GS; Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, United States., Liang BT; Pat and Jim Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, Connecticut 06030, United States., Breton S; Centre de Recherche du CHU de Québec, Département d'Obstétrique, de Gynécologie et Reproduction, Faculté de Médecine, Université Laval, Laval, Québec G1V 4G2, Canada., Salvemini D; Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, Missouri 63104, United States., Cook DN; Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, United States., Jacobson KA; Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
المصدر: Journal of medicinal chemistry [J Med Chem] 2023 Jul 13; Vol. 66 (13), pp. 9076-9094. Date of Electronic Publication: 2023 Jun 29.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
أسماء مطبوعة: Publication: Washington Dc : American Chemical Society
Original Publication: [Easton, Pa.] : American Chemical Society, [c1963-
مواضيع طبية MeSH: Receptors, Purinergic P2*/metabolism, Mice ; Animals ; Naphthalenes/pharmacology ; Naphthalenes/therapeutic use ; Uridine Diphosphate Glucose/metabolism
مستخلص: P2Y 14 receptor (P2Y 14 R) is activated by extracellular UDP-glucose, a damage-associated molecular pattern that promotes inflammation in the kidney, lung, fat tissue, and elsewhere. Thus, selective P2Y 14 R antagonists are potentially useful for inflammatory and metabolic diseases. The piperidine ring size of potent, competitive P2Y 14 R antagonist (4-phenyl-2-naphthoic acid derivative) PPTN 1 was varied from 4- to 8-membered rings, with bridging/functional substitution. Conformationally and sterically modified isosteres included N -containing spirocyclic ( 6 - 9 ), fused ( 11 - 13 ), and bridged ( 14 , 15 ) or large ( 16 - 20 ) ring systems, either saturated or containing alkene or hydroxy/methoxy groups. The alicyclic amines displayed structural preference. An α-hydroxyl group increased the affinity of 4-(4-((1 R ,5 S ,6 r )-6-hydroxy-3-azabicyclo[3.1.1]heptan-6-yl)phenyl)-7-(4-(trifluoromethyl)phenyl)-2-naphthoic acid 15 (MRS4833) compared to 14 by 89-fold. 15 but not its double prodrug 50 reduced airway eosinophilia in a protease-mediated asthma model, and orally administered 15 and prodrugs reversed chronic neuropathic pain (mouse CCI model). Thus, we identified novel drug leads having in vivo efficacy.
References: Front Immunol. 2022 Mar 30;13:870183. (PMID: 35432308)
JCI Insight. 2021 May 24;6(10):. (PMID: 34027896)
J Clin Invest. 2021 Apr 1;131(7):. (PMID: 33792561)
J Med Chem. 2022 Feb 24;65(4):3434-3459. (PMID: 35113556)
J Med Chem. 2018 Jun 14;61(11):4860-4882. (PMID: 29767967)
Nature. 2012 Dec 13;492(7428):215-20. (PMID: 23235874)
Chem Rev. 2014 Aug 27;114(16):8257-322. (PMID: 25003801)
Nephron. 2022;146(3):268-273. (PMID: 34657041)
Pain. 1988 Apr;33(1):87-107. (PMID: 2837713)
J Med Chem. 2020 Sep 10;63(17):9563-9589. (PMID: 32787142)
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1062-6. (PMID: 24462664)
Cells. 2021 May 04;10(5):. (PMID: 34064383)
Am J Respir Cell Mol Biol. 2005 Dec;33(6):601-9. (PMID: 16109883)
Bioorg Med Chem. 2009 Jul 15;17(14):5298-311. (PMID: 19502066)
Mol Pharmacol. 2013 Jul;84(1):41-9. (PMID: 23592514)
J Med Chem. 2001 Jul 5;44(14):2276-85. (PMID: 11428921)
RSC Med Chem. 2021 Apr 12;12(5):758-766. (PMID: 34124674)
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4366-8. (PMID: 21689930)
ChemMedChem. 2022 May 4;17(9):e202200020. (PMID: 35263505)
ACS Med Chem Lett. 2020 Apr 30;11(6):1281-1286. (PMID: 32551012)
J Med Chem. 2022 Jul 14;65(13):8699-8712. (PMID: 35730680)
J Med Chem. 2021 Jun 10;64(11):7210-7230. (PMID: 33983732)
Curr Pharm Des. 2012;18(9):1292-310. (PMID: 22316157)
J Med Chem. 2022 Dec 8;65(23):15967-15990. (PMID: 36394994)
Eur J Med Chem. 2022 Jan 5;227:113933. (PMID: 34689072)
Org Lett. 2019 Jul 19;21(14):5611-5615. (PMID: 31251637)
Nat Methods. 2017 Oct;14(10):987-994. (PMID: 28869757)
J Biomol Screen. 2011 Oct;16(9):1098-105. (PMID: 21821827)
Cardiol Res Pract. 2020 Apr 22;2020:4375127. (PMID: 32377427)
Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2054-8. (PMID: 19820193)
J Clin Invest. 2020 Jul 1;130(7):3734-3749. (PMID: 32287042)
Elife. 2021 Jul 16;10:. (PMID: 34269178)
J Med Chem. 2010 Mar 25;53(6):2601-11. (PMID: 20175530)
Elife. 2022 Mar 21;11:. (PMID: 35311647)
J Physiol. 2017 Dec 1;595(23):7135-7148. (PMID: 28980705)
Biochem Pharmacol. 2020 Apr;174:113796. (PMID: 31926938)
J Chromatogr A. 2004 May 28;1037(1-2):299-310. (PMID: 15214672)
J Med Chem. 2021 Apr 22;64(8):5099-5122. (PMID: 33787273)
ACS Chem Biol. 2014 Dec 19;9(12):2833-42. (PMID: 25299434)
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108. (PMID: 4202581)
Bioorg Med Chem. 2022 Mar 1;57:116650. (PMID: 35123178)
J Org Chem. 2007 Aug 17;72(17):6599-601. (PMID: 17630799)
J Immunol. 2009 Jun 1;182(11):7074-84. (PMID: 19454705)
J Med Chem. 2015 Apr 9;58(7):2895-940. (PMID: 25565044)
Angew Chem Int Ed Engl. 2010 May 3;49(20):3524-7. (PMID: 20544904)
J Immunol. 2012 Aug 15;189(4):1992-9. (PMID: 22778393)
J Immunol. 2022 Oct 15;209(8):1574-1585. (PMID: 36165184)
معلومات مُعتمدة: Z01 DK031116 United States ImNIH Intramural NIH HHS; ZIA DK031116 United States ImNIH Intramural NIH HHS; HHSN271200800025C United States MH NIMH NIH HHS
المشرفين على المادة: QLG01V0W2L (2-naphthoic acid)
0 (Receptors, Purinergic P2)
0 (Naphthalenes)
V50K1D7P4Y (Uridine Diphosphate Glucose)
تواريخ الأحداث: Date Created: 20230629 Date Completed: 20230714 Latest Revision: 20240714
رمز التحديث: 20240714
مُعرف محوري في PubMed: PMC10407959
DOI: 10.1021/acs.jmedchem.3c00664
PMID: 37382926
قاعدة البيانات: MEDLINE
الوصف
تدمد:1520-4804
DOI:10.1021/acs.jmedchem.3c00664